Zacks Research Issues Negative Forecast for Avantor Earnings

Avantor, Inc. (NYSE:AVTR) – Equities research analysts at Zacks Research decreased their Q3 2025 earnings estimates for Avantor in a research report issued on Friday, October 18th. Zacks Research analyst D. Dey now anticipates that the company will post earnings of $0.28 per share for the quarter, down from their prior forecast of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. Zacks Research also issued estimates for Avantor’s Q4 2025 earnings at $0.35 EPS and FY2026 earnings at $1.35 EPS.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a net margin of 5.28% and a return on equity of 12.40%. The firm had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion.

Other research analysts also recently issued research reports about the stock. Stifel Nicolaus raised their price target on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Evercore ISI decreased their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 2nd. Citigroup downgraded Avantor from a “buy” rating to a “neutral” rating and cut their price objective for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Finally, Robert W. Baird upped their target price on Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $28.00.

Avantor Stock Performance

Shares of NYSE AVTR opened at $24.73 on Monday. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. Avantor has a one year low of $16.63 and a one year high of $28.00. The business’s 50-day moving average price is $25.65 and its two-hundred day moving average price is $24.33. The company has a market capitalization of $16.80 billion, a P/E ratio of 63.41, a price-to-earnings-growth ratio of 2.93 and a beta of 1.33.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Avantor

Large investors have recently modified their holdings of the stock. Jennison Associates LLC lifted its stake in shares of Avantor by 113.0% during the first quarter. Jennison Associates LLC now owns 2,497,349 shares of the company’s stock valued at $63,857,000 after acquiring an additional 1,325,026 shares during the period. Swedbank AB acquired a new position in Avantor during the 1st quarter valued at about $2,707,000. Diversify Advisory Services LLC bought a new position in shares of Avantor in the 1st quarter valued at about $908,000. Oliver Luxxe Assets LLC acquired a new stake in shares of Avantor during the 1st quarter worth approximately $1,538,000. Finally, BNP Paribas Financial Markets raised its stake in shares of Avantor by 42.4% during the first quarter. BNP Paribas Financial Markets now owns 309,394 shares of the company’s stock worth $7,911,000 after buying an additional 92,098 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.